IL6 and cancer: Liang et al. have shown that heat shock protein beta-1 (HSPB1) overexpression in breast cancer is linked to EMT and IL-6-driven M2-type macrophage infiltration, and this promotes cancer progression and resistance to doxorubicin mediated by NF-κB signaling [110].